atogepant

Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity
BioSpace
Fri, 06/4/21 - 10:37 am
AbbVie
migraines
atogepant
AbbVie Receives NDA for Atogepant, Aims to Stop Migraines in Their Tracks
BioSpace
Wed, 03/31/21 - 10:58 pm
AbbVie
atogepant
migraines
FDA
AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data
Endpoints
Thu, 07/30/20 - 10:56 am
AbbVie
migraine
Nurtec
atogepant
Biohaven
Allergan's Migraine Prevention Drug Meets Primary Endpoints in Ph Iib/III Study
CP Wire
Mon, 06/11/18 - 09:15 am
migraines
Allergan
atogepant